Tech Company Financing Transactions

Sionna Therapeutics Funding Round

Sionna Therapeutics closed a $182 million Series C funding round on 3/7/2024. Backers included Enavate Sciences, Perceptive Advisors and Viking Global Investors.

Transaction Overview

Company Name
Sionna Therapeutics
Announced On
3/7/2024
Transaction Type
Venture Equity
Amount
$182,000,000
Round
Series C
Investors

Enavate Sciences (Lead Investor)

Perceptive Advisors (Lead Investor)

Viking Global Investors (Lead Investor)

Atlas Venture

Cystic Fibrosis Foundation

OrbiMed (Peter Thompson)

Q Healthcare Holdings

RA Capital

T. Rowe Price

The Rise Fund

Proceeds Purpose
The company intends to use the funds to support the clinical development of first-in-class small molecules designed to fully restore the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein by stabilizing the first nucleotide-binding domain (NBD1).

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
22 Strathmore Road
Natick, MA 01760
United States
Phone
Undisclosed
Website
www.sionnatx.com
Email Address
Not Recorded
Overview
Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis
Profile
Sionna Therapeutics LinkedIn Company Profile
Social Media
Sionna Therapeutics Company Twitter Account
Company News
Sionna Therapeutics News
Facebook
Sionna Therapeutics on Facebook
YouTube
Sionna Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Financial Officer
Elena Ridloff
  Elena Ridloff LinkedIn Profile  Elena Ridloff Twitter Account  Elena Ridloff News  Elena Ridloff on Facebook
Chief Medical Officer
Charlotte McKee
  Charlotte McKee LinkedIn Profile  Charlotte McKee Twitter Account  Charlotte McKee News  Charlotte McKee on Facebook
Chief Scientific Officer
John Macor
  John Macor LinkedIn Profile  John Macor Twitter Account  John Macor News  John Macor on Facebook
Co-Founder
Greg Hurlbut
  Greg Hurlbut LinkedIn Profile  Greg Hurlbut Twitter Account  Greg Hurlbut News  Greg Hurlbut on Facebook
President
Mike Cloonan
  Mike Cloonan LinkedIn Profile  Mike Cloonan Twitter Account  Mike Cloonan News  Mike Cloonan on Facebook

 

 

Browse more venture capital transactions:

Prev: 3/7/2024: Vescent Photonics venture capital transaction
Next: 3/7/2024: Pro Shop venture capital transaction

 

Share this article

 

About Database of VC Transactions

We record tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.